Analysts predict that Nu Skin Enterprises, Inc. (NYSE:NUS) will post $663.70 million in sales for the current quarter, Zacks reports. Four analysts have issued estimates for Nu Skin Enterprises’ earnings, with estimates ranging from $659.30 million to $667.44 million. Nu Skin Enterprises posted sales of $563.70 million during the same quarter last year, which suggests a positive year over year growth rate of 17.7%. The company is expected to report its next earnings results after the market closes on Wednesday, November 7th.
According to Zacks, analysts expect that Nu Skin Enterprises will report full-year sales of $2.65 billion for the current year, with estimates ranging from $2.64 billion to $2.65 billion. For the next financial year, analysts expect that the firm will post sales of $2.69 billion, with estimates ranging from $2.54 billion to $2.78 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research firms that that provide coverage for Nu Skin Enterprises.
NUS has been the subject of a number of analyst reports. Zacks Investment Research raised Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $95.00 price target for the company in a research report on Monday, August 6th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $98.00 price target on shares of Nu Skin Enterprises in a research report on Tuesday, September 4th. Stifel Nicolaus raised Nu Skin Enterprises from a “sell” rating to a “hold” rating and boosted their price target for the stock from $57.00 to $70.00 in a research report on Thursday, August 2nd. They noted that the move was a valuation call. Finally, DA Davidson initiated coverage on Nu Skin Enterprises in a research report on Tuesday, October 9th. They issued a “buy” rating and a $92.00 price target for the company. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $86.29.
In related news, insider Joseph Y. Chang sold 10,600 shares of the business’s stock in a transaction dated Thursday, August 9th. The stock was sold at an average price of $82.13, for a total transaction of $870,578.00. Following the completion of the transaction, the insider now owns 63,416 shares of the company’s stock, valued at approximately $5,208,356.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel D Matthew Dorny sold 3,750 shares of the business’s stock in a transaction dated Friday, August 10th. The stock was sold at an average price of $81.84, for a total value of $306,900.00. Following the transaction, the general counsel now directly owns 33,871 shares of the company’s stock, valued at approximately $2,772,002.64. The disclosure for this sale can be found here. Insiders sold 19,350 shares of company stock valued at $1,582,678 in the last ninety days. Insiders own 3.00% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Los Angeles Capital Management & Equity Research Inc. lifted its position in shares of Nu Skin Enterprises by 410.1% during the 3rd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 427,800 shares of the company’s stock worth $35,259,000 after purchasing an additional 343,935 shares during the last quarter. WINTON GROUP Ltd lifted its position in shares of Nu Skin Enterprises by 1,623.7% during the 3rd quarter. WINTON GROUP Ltd now owns 158,268 shares of the company’s stock worth $13,044,000 after purchasing an additional 149,086 shares during the last quarter. Cambridge Investment Research Advisors Inc. lifted its position in shares of Nu Skin Enterprises by 21.3% during the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 4,255 shares of the company’s stock worth $351,000 after purchasing an additional 746 shares during the last quarter. Engineers Gate Manager LP acquired a new position in shares of Nu Skin Enterprises during the 3rd quarter worth about $204,000. Finally, Sterling Capital Management LLC lifted its position in shares of Nu Skin Enterprises by 18.3% during the 3rd quarter. Sterling Capital Management LLC now owns 38,189 shares of the company’s stock worth $3,148,000 after purchasing an additional 5,911 shares during the last quarter. 76.47% of the stock is owned by institutional investors and hedge funds.
NUS traded up $0.93 during trading on Friday, reaching $73.16. 8,141 shares of the stock traded hands, compared to its average volume of 416,008. The stock has a market cap of $3.98 billion, a price-to-earnings ratio of 22.65, a PEG ratio of 1.75 and a beta of 1.04. Nu Skin Enterprises has a fifty-two week low of $59.79 and a fifty-two week high of $88.68. The company has a current ratio of 1.82, a quick ratio of 1.19 and a debt-to-equity ratio of 0.46.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Featured Story: Inflation
Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.